Skip to main content
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
27.94
+1.00 (3.71%)
Oct 24, 2024, 4:00 PM EDT - Market closed

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $1.86M in the quarter ending June 30, 2024, with 92.26% growth. This brings the company's revenue in the last twelve months to $4.12M, up 8.57% year-over-year. In the year 2023, Dianthus Therapeutics had annual revenue of $2.83M, down -55.96%.

Revenue (ttm)
$4.12M
Revenue Growth
+8.57%
P/S Ratio
134.85
Revenue / Employee
$77,698
Employees
53
Market Cap
820.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

DNTH News

More News